title: Con: The black box warning on droperidol should not be removed (but should be clarified!).
authors.forename: Danielle B
authors.initials: DB
authors.lastname: Ludwin
authors.forename: Steven L
authors.initials: SL
authors.lastname: Shafer
mesh_terms: D000932:Antiemetics / Q000009:adverse effects*; D003257:Consumer Product Safety; D004305:Dose-Response Relationship, Drug; D004329:Droperidol / Q000009:adverse effects*; D017277:Drug Approval; D004348:Drug Labeling; D004363:Drug Utilization; D019317:Evidence-Based Medicine; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced / Q000503:physiopathology; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D009626:Terminology as Topic; D016171:Torsades de Pointes / Q000139:chemically induced / Q000503:physiopathology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000932:Antiemetics; D004329:Droperidol